For example, procoagulant endothelial EVs are released due to endothelial damage, TNF-α [27], or complement activation [28] resulting in coagulation and venous thromboembolism, presented in COVID-19, as deep vein thrombosis or pulmonary embolism. This evidence concerns the gene TNF and COVID-19.